Physician

Michael J. Banach, MD

According to 2025 Medicare claims, Michael Banach, MD (NPI: 1710972310) practices ophthalmology in the Harrisburg-Carlisle, PA market, with the plurality of this provider's patient population coming from Cumberland, PA. This provider's primary affiliated billing organization is PENNSYLVANIA RETINA SPECIALISTS PC (NPI: 1568428126; TIN: 232152842) and primary practice location at 17011-1776.

Banach's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 702 traditional Medicare patients, billed 40,001 HCPCS/CPT codes, and received $2,171,744 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 499 prescription claims across 155 beneficiaries totaling $195,745 in drug costs, led by Eylea (Aflibercept). Open Payments data shows 7 records totaling $258. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $15,504 to $195,745. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$2.9M2015 Medicare payment: $1,795,064 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,549,558 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,288,305 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,500,615 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,947,041 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,633,494 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,582,552 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,281,300 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,148,088 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,171,744 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20158349,507$1,795,064
20161,08113,138$2,549,558
201790311,361$2,288,305
201889111,774$2,500,615
20191,10514,426$2,947,041
202090912,157$2,633,494
202184311,438$2,582,552
202276113,465$2,281,300
202373633,322$2,148,088
202470240,001$2,171,744

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$98K$196K2015 Drug cost: $15,504 (USD; Tot_Drug_Cst)2016 Drug cost: $21,017 (USD; Tot_Drug_Cst)2017 Drug cost: $17,325 (USD; Tot_Drug_Cst)2018 Drug cost: $34,880 (USD; Tot_Drug_Cst)2019 Drug cost: $73,167 (USD; Tot_Drug_Cst)2020 Drug cost: $114,175 (USD; Tot_Drug_Cst)2021 Drug cost: $175,843 (USD; Tot_Drug_Cst)2022 Drug cost: $121,010 (USD; Tot_Drug_Cst)2023 Drug cost: $141,842 (USD; Tot_Drug_Cst)2024 Drug cost: $195,745 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015142357$15,504
2016149407$21,017
2017149412$17,325
2018153378$34,880
2019148340$73,167
2020146419$114,175
2021151493$175,843
2022118338$121,010
2023127368$141,842
2024155499$195,745

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system419449$85
67028Injection of drug into eye3461,408$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more361685$67
92134Imaging of retina5461,656$29
92250Photography of the retina247280$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EyleaAflibercept441,354$130,179
VabysmoFaricimab-Svoa13366$37,028
Prednisolone AcetatePrednisolone Acetate1266,190$4,577
Brimonidine TartrateBrimonidine Tartrate231,120$1,636
Ketorolac TromethamineKetorolac Tromethamine902,995$1,233

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$258Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael J. Banach, MD?

Tedicare shows public-source Medicare data for Michael J. Banach, MD (NPI 1710972310), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael J. Banach, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael J. Banach, MD?

Michael J. Banach, MD is linked to PENNSYLVANIA RETINA SPECIALISTS PC (billing NPI 1568428126) in the available physician profile data.

Does Michael J. Banach, MD have Open Payments data?

Michael J. Banach, MD has 7 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.